Transforming high-content screening with intelligent imaging and AI analysis
June 26, 2025 at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
High-content imaging is essential in drug discovery, but as assays grow more complex, researchers need faster, more powerful imaging and analysis tools to extract high-quality data efficiently.
Register for this exclusive webinar to hear from two Molecular Devices experts, Dr. Angeline Lim and Dr. Andy Bashford, as they share real-world applications, including phenotypic profiling and patient-derived organoid imaging, using a next-generation high-content screening system - ImageXpress® HCS.ai.
Discover how this platform can elevate your screening and image capturing with its enhanced imaging quality and AI-powered analysis, to improve assay reproducibility, produce deeper insights and take your screening to the next level.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Speakers
Moderator
Who should attend?
- Scientists, directors, managers and imaging specialists working in biotech, pharma and academic sectors.
Featured products
Request Quote for All Products
ImageXpress HCS.ai High-Content Screening System
Molecular Devices®A fast, intuitive and versatile system delivering deeper insights for every lab
What will this webinar cover?
- Master essential high-content imaging assays from 2D phenotypic profiling to 3D imaging using patient-derived organoids
- Discover the latest innovations in the ImageXpress HCS.ai platform and how it enhances speed, quality, and flexibility
- Explore the power of AI-driven analysis with IN Carta software to tackle the most challenging screening assays
